trending Market Intelligence /marketintelligence/en/news-insights/trending/jtl01cyg1xqyyiqzhaxdaw2 content esgSubNav
In This List

Immune Pharmaceuticals director resigns

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Immune Pharmaceuticals director resigns

Immune Pharmaceuticals Inc. said Cameron Durrant resigned as a director.

Englewood Cliffs, N.J.-based Immune Pharmaceuticals develops treatments for immunologic and inflammatory diseases.